Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society

    NEW PUBLICATION: EMAS is extremely proud to announce publication of a new clinical guide on Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society.   Women’s health is increasingly recognized as a global health priority and the complications of estrogen deficiency and ageing present an enormous problem to…

EMAS position statement: The essential menopause curriculum for healthcare professionals

The European Menopause and Andropause Society (EMAS) is very proud to announce their new position statement about the essential menopause curriculum for healthcare professionals. It shows that managing perimenopausal and postmenopausal health is a key issue for all areas of healthcare, not just gynecology.   This position statement provides recommendations for the curriculum of education…

EMAS position statement: menopause symptom management in women with dyslipidemias

Amsterdam, 4 April, 2020 – A new clinical guide by the European Menopause and Andropause Society (EMAS) published in the journal Maturitas provides an evidence-based approach to the menopausal symptom management in women with dyslipidemias (abnormal lipid levels), as well as to the management of dyslipidemias in postmenopausal women. Dyslipidemias are quite common disorders, constituting…

Management of depressive symptoms in peri- and post-menopausal women: EMAS Clinical Guide

Amsterdam, 7 November 2019 – A new position statement by the European Menopause and Andropause Society (EMAS) published in the journal Maturitas summarises the evidence about management of depression at the menopause. Globally, the total number of people with depression exceeds 300 million with a 70% greater incidence in women. The perimenopause is considered to…